Clinical Trial: Expression of Optic Atrophy Type 1 (OPA1) Protein in Lung Adenocarcinoma

Study Status: Completed
Recruit Status: Unknown status
Study Type: Observational

Official Title:

Brief Summary: Optic atrophy type 1(OPA1) is a nuclear dynamin-related GTPase, targeted to the inner mitochondrial membrane, which plays a role in mitochondrial fusion. Mitochondria fusion is associated with process of apoptosis. . OPA1 plays an important role in the mitochondrial bioenergetics and mitochondrial networks. The changes in mitochondrial shape and mitochondrial bioenergetics may be cause of the disease. In this study, we investigate the expression of OPA1 in lung adenocarcinoma (LADC) cells and tissue.

Detailed Summary:
Sponsor: China Medical University Hospital

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: China Medical University Hospital

Dates:
Date Received: November 24, 2010
Date Started: August 2010
Date Completion:
Last Updated: November 26, 2010
Last Verified: November 2010